UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Cancer science, 2010-01, Vol.101 (1), p.161-166

2010

Volltextzugriff (PDF)

Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer

Cancer science, 2023-02, Vol.114 (2), p.546-560

2023

Volltextzugriff (PDF)

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Nature communications, 2020-01, Vol.11 (1), p.74-16, Article 74

2020

Volltextzugriff (PDF)

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Scientific reports, 2017-03, Vol.7 (1), p.45124-45124, Article 45124

2017

Volltextzugriff (PDF)

Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients

BMC cancer, 2024-08, Vol.24 (1), p.1-10

2024

Volltextzugriff (PDF)

ABCC11/MRP8 confers pemetrexed resistance in lung cancer

Cancer science, 2010-11, Vol.101 (11), p.2404-2410

2010

Volltextzugriff (PDF)

Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model

Molecular cancer research, 2019-01, Vol.17 (1), p.212-224

2019

Volltextzugriff (PDF)

Significance of c‐MET overexpression in cytotoxic anticancer drug‐resistant small‐cell lung cancer cells

Cancer science, 2014-08, Vol.105 (8), p.1032-1039

2014

Volltextzugriff (PDF)

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

Scientific reports, 2021-12, Vol.11 (1), p.23677-23677, Article 23677

2021

Volltextzugriff (PDF)

PD-L1 Expression in Small Cell Lung Cancer

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.e40-e41

2018

Volltextzugriff (PDF)

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer

Journal of radiation research, 2023-01, Vol.64 (1), p.142-153

2023

Volltextzugriff (PDF)

MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression

Cell death & disease, 2020-03, Vol.11 (3), p.177-177, Article 177

2020

Volltextzugriff (PDF)

Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

Scientific reports, 2023-02, Vol.13 (1), p.2117-2117, Article 2117

2023

Volltextzugriff (PDF)

Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model

Molecular cancer therapeutics, 2020-06, Vol.19 (6), p.1320-1327

2020

Volltextzugriff (PDF)

Paratracheal Middle Mediastinal Thymic Carcinomas

The Annals of thoracic surgery, 2020-07, Vol.110 (1), p.e39-e41

2020

Volltextzugriff (PDF)

Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer

Journal of radiation research, 2022-07, Vol.63 (4), p.636-645

2022

Volltextzugriff (PDF)

High-Dose Crizotinib for Brain Metastases Refractory to Standard-Dose Crizotinib

Journal of thoracic oncology, 2013-09, Vol.8 (9), p.e85-e86

2013

Volltextzugriff (PDF)

Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study

Journal of pharmaceutical health care and sciences, 2024-08, Vol.10 (1), p.52-7

2024

Volltextzugriff (PDF)

MRP8/ABCC11 directly confers resistance to 5-fluorouracil

Molecular cancer therapeutics, 2007-01, Vol.6 (1), p.122-127

2007

Volltextzugriff (PDF)

Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer

Cancer chemotherapy and pharmacology, 2015-05, Vol.75 (5), p.985-991

2015

Volltextzugriff (PDF)

Detection of a co-mutation in the epidermal growth factor receptor gene exon 20 H773L/V774M by FoundationOne test and treatment with osimertinib: A case report

Current problems in cancer. Case reports, 2024-06, Vol.14, p.100286, Article 100286

2024

Volltextzugriff (PDF)

Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer

NPJ precision oncology, 2023-01, Vol.7 (1), p.12-13, Article 12

2023

Volltextzugriff (PDF)

Adjuvant Chemotherapy After Neoadjuvant Therapy and Surgery for Non-Small Cell Lung Cancer

Annals of thoracic surgery short reports, 2024-09, Vol.2 (3), p.469-473

2024

Volltextzugriff (PDF)

MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

Molecular cancer therapeutics, 2008-05, Vol.7 (5), p.1150-1155

2008

Volltextzugriff (PDF)

Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target

Translational lung cancer research, 2024-03, Vol.13 (3), p.689-693

2024

Volltextzugriff (PDF)

1 – 25 von 204

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(184)

Publikationsform

Artikel
(196)
Berichte
(8)

Sprache

Englisch
(174)
Japanisch
(72)

Erscheinungsjahr

n.n

Thema

Science & Technology
(91)
Life Sciences & Biomedicine
(84)
Humans
(65)
Oncology
(48)
Female
(43)
Male
(40)
Aged
(33)
Middle Aged
(32)
Lung Cancer
(31)
Adult
(25)
Lung Neoplasms - Drug Therapy
(22)
Chemotherapy
(19)
Lung Neoplasms - Genetics
(18)
Aged, 80 And Over
(17)
Lung Neoplasms - Pathology
(17)
Patients
(15)
Tumors
(15)
Carcinoma, Non-Small-Cell Lung - Genetics
(14)
Fukushima Nuclear Accident
(14)
Medical Prognosis
(14)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

Significance of thymidylate synthase for resistance to pemetrexed in lung cancer

Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer

YAP1 mediates survival of ALK-rearranged lung cancer cells treated with alectinib via pro-apoptotic protein regulation

Clinical Impact of Single Nucleotide Polymorphism in PD-L1 on Response to Nivolumab for Advanced Non-Small-Cell Lung Cancer Patients

Performance status improvement and advances in systemic treatment after brain metastases resection: a retrospective single-center cohort study of non-small cell lung cancer patients

ABCC11/MRP8 confers pemetrexed resistance in lung cancer

Alectinib Resistance in ALK-Rearranged Lung Cancer by Dual Salvage Signaling in a Clinically Paired Resistance Model

Significance of c‐MET overexpression in cytotoxic anticancer drug‐resistant small‐cell lung cancer cells

Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

PD-L1 Expression in Small Cell Lung Cancer

Recurrence patterns and progression-free survival after chemoradiotherapy with or without consolidation durvalumab for stage III non-small cell lung cancer

MCL1 inhibition is effective against a subset of small-cell lung cancer with high MCL1 and low BCL-XL expression

Author Correction: Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer

Acquired Resistance to Alectinib in ALK-Rearranged Lung Cancer due to ABCC11/MRP8 Overexpression in a Clinically Paired Resistance Model

Paratracheal Middle Mediastinal Thymic Carcinomas

Usefulness of pro-gastrin-releasing peptide as a predictor of the incidence of brain metastasis and effect of prophylactic cranial irradiation in patients with limited-stage small-cell lung cancer

High-Dose Crizotinib for Brain Metastases Refractory to Standard-Dose Crizotinib

Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study

MRP8/ABCC11 directly confers resistance to 5-fluorouracil

Organic cation transporter OCT6 mediates cisplatin uptake and resistance to cisplatin in lung cancer

Detection of a co-mutation in the epidermal growth factor receptor gene exon 20 H773L/V774M by FoundationOne test and treatment with osimertinib: A case report

Adaptive resistance to lorlatinib via EGFR signaling in ALK-rearranged lung cancer

Adjuvant Chemotherapy After Neoadjuvant Therapy and Surgery for Non-Small Cell Lung Cancer

MRP7/ABCC10 expression is a predictive biomarker for the resistance to paclitaxel in non-small cell lung cancer

Aurora kinase B inhibition in small-cell lung cancer: BCL-2 as a potential therapeutic biomarker and combination target

Suchergebnisse filtern